House Prioritizes Patient Safety; Rejects “Right-To-Try” Legislation
The House of Representatives tonight rejected legislation that would have changed the process for accessing experimental drugs without including necessary patient safeguards. The Right-to-Try legislation was opposed by the American Cancer Society Cancer Action Network (ACS CAN) along with more than 85 other organizations representing millions of patients.